Hypolipidemic effect of Aegle Marmelos leaf extract in streptozotocin (STZ) induced diabetic male Albino rats

International Journal of PharmTech Research

Volumn 2, Issue 1, 2010, Pages 259-265

  Devi, K ^a   Sivaraj, A ^b   Kumar, P Vinoth ^b   Ahmed, K Syed Zameer ^b   Sathiyaraj, K ^b   Kumar, B Senthil ^b   David, E ^c  

^a DKM College for Women   (India)

^b C ABDUL HAKEEM COLLEGE   (India)

^c VOORHEES COLLEGE   (India)

Author keywords

Aegle marmelos; Diabetes; Hyperlipidemia; Streptozotocin (STZ)

Indexed keywords

AEGLE MARMELOS EXTRACT; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; STREPTOZOCIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HYPERLIPIDEMIA; HYPOLIPEMIA; MALE; NONHUMAN; PLANT LEAF; RAT; STREPTOZOCIN DIABETES;

EID: 77953471534     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. th ed., Chap.60, New York, the McGraw-Hill Companies Inc.1996, 1487-1518.
2. Garrey, W.T., Huecksteadt, Y.P and Birnbraum, M.J. Science, 1989, 245, 60-63.
3. Kent, J.D., Kimball, S.R. and Jefferson, L.S. Am. J. Physiol., 1991, 260, C490-C516.
4. Rodrigues and McNeill, J.H. Cardiovas. Re, 1992, 26, 913-922.
5. Wohaieb, S.A. And Godin, D.V. Diabetes, 1987, 36, 1014-1018.
6. Sun Q, Sekar N, Goldwaser I, Genshonov E, Fridkin M, Shechter Y. Vanadate restores glucose 6 phosphate in diabetic rats: a mechanism to enhance glucose metabolism. Am.J physiol Endocrinol metab, 2000 Aug, 279(2): E403-410.
7. Hemalatha S, Wahi A.K, Singh P.N, and Chansouria J.P.N. Hypoglycemic activity of Withania Coaculants Dunal in streptozotocin induced diabetic rats. J. Ethnopharmacol, 2004, 93:261-264.
8. Bailey, C.J. And Day, C. Traditional plants medicines as treatment for diabetes. Diabetes care, 1989, 12: 553-64
9. Vinuthan, M.K., Grish kumar, V., Narayanaswamy, M and Veena, T. Lipid lowering effect of aqueous leaves extract of murraya koenigii (curry leaves) on alloxon - induced male diabetic rats. Phcog mag, Apr-Jun, 2007, Vol 3, issue 10.
10. Mhaskar K.S, Blatter E and Caius J.F. (eds.) In: Indian Medicinal plants published by Indian Books centre, Delhi, India, 2000, Vol.IV 1212-1214.
11. Bursell SE., Takagi C., Clermont AC., Takagi H., Mori F., Ishii H., King, GL,. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats. Invest ophtalmol Vis Sci, 1997 Dec, 38(13): 2711-2720.
12. Parekh A.C, Jung D.M. Cholesterol determination with ferric acetate-uranium acetate and sulphuric acid, ferrous sulphate reagents, 1970, 42; 1423-1427.
13. Rice L.B. Determination of triglycerides (enzymatic method) Clin. Chem, 1970, 31(5): 746-750.
14. Lyons, T.J. Lipoprotein glycation and its metabolic complications. Diabetes, 1992, 41. (suppl.2) 67-73.
15. Burstein R.F and Scholnick V.S, Biochemistry and methodology of lipids. J Lipid Res, 1972, 25: 375-382.
16. Laakso M. Lipids and lipoprotein as risk factors for coronary heart disease in non-insulin dependent diabetes mellitus. Ann. Med, 1996, 28, 341-345.
17. Steiner G. Risk factors for macro vascular disease in type 2 diabetes: Classic lipid abnormalities. Diabetes care, 1999, 22 (suppl,3), C6-C9.
18. Massing, M.W., Sueta, C.A., Chowdhury, M., Biggs, D.P., Simpson, R.J. Jr. Lipid management among coronary artery disease patients in diabetes mellitus or advanced age. American Journal of cardiology, 2001, 87: 646-664.
19. Flodstrom M, Tyrberg B, Eizirik DL, Sandler S. Reduced sensitivity of inducible nitric oxide synthetase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes, 1999, Apr; 48(4):706-713.
20. Rao VS, Santos FA, Silva RM, Teixiera MG. Effects of nitric oxide synthetase inhibitor and melatonin on the hyperglycemic response to streptozotocin in rats. Vascul Pharmacol, 2002 Mar, 38(3):127-130.
21. Sperling M.A, Saunders P.A. Diabetes mellitus in: R.E. Behrman R.M, Kliegman H.B, Jenson (Eds) Nelson text book of pediatrics, 2000, 1767-1791.
22. Bhagavan N.V. Metabolic homeostasis in: N.V. Bhagavan (Eds) Medical biochemistry Harcourt/Academic, Florida, 2002, 485-519.
23. Ranganathan G, Li C, Kern P.A. The translational regulation of lipoprotein lipase in diabetic rats involves the 3′-untransalted region of lipoprotein lipase mRNA. J.Biol.Chem, 2000, 275:40986-40991.
24. Ginsberg H.N. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. Diabetes care, 1991, 14: 839-855.
25. Coppack S.W, Jenson M.D, Miles J.M. In vivo regulation of lipolysis in human. J. lipid Res, 1994, 35:177-193.
26. Ohno T, Horio F, Tanaka S, Terada M, Namikawa T and kitoh J. Fatty liver and hyperlipidemia in IDDM of streptozotocin treated shrews. Life Sci, 2000, 66:125-131.
27. Bopanna K.N, Kannan J, Sushma gangil, Balaraman R, Rathod S.P. Antidiabetic and anti hyperlipidemic effect of Neem, Lipidemic effect of Neem seed kernel powder on alloxon diabetic rabbits. Ind. J. Pharmacology, 1997, 29:162-167.